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HIV infection has been considered as a 
chronic illness since the availability of highly 
active anti retroviral treatments (HAART). The 
introduction of HAART to HIV/AIDS patient 
improve quality of life, life expectancy, decrease 
rate of resistance and further decrease mortality 
to AIDS related causes. Many studies showed 
the evidence of HAART efficacy to suppress 
viral replication among patient with continuum 
adherence to treatment. However, unlike other 
chronic medications which were only needed 
at least 70% adherence; success virological 
suppression rate in HIV/AIDS in patient required 
as high as 95% or near perfect adherence; and 
this remains to be an important issue for patient 
on HAART.1
In term of treatment, a long-term follow up of 
patient’s adherence, i.e. daily medication intake 
monitoring for life, becomes a routine practice. 
However, no gold standard is established 
to measure patients’ adherence. Thus in the 
beginning of treatment, assessment on how 
patient would be ready to take medication, 
existing any limitations such as mental illness 
or active drug use, understanding of disease and 
regimen, social support and patient schedule, 
should be asses. Clinicians have to educate 
patient starting on HIV treatment for having 
very low missed doses, and this was based on 
evidence we have from a decades ago. By that 
time, treatment regimens were more complex. 
Lowering the threshold of adherence would not 
be possible because allowing for missed dose 
will only favor to poor compliance within time. 
Then, continuous support and intervention during 
treatment are needed to maintain high level of 
adherence to HAART intake.2
There has been significant progress made 
regarding determinants, measurements, 
and interventions to improve adherence to 
antiretroviral therapies. Systematic review 
on factors related to adherence of treatment 
classified several factors contributed to failure 
on adherence included: (1) patient related factor 
such as mental illness or physical symptoms, 
(2) beliefs about the medications, (3) life long 
treatment and (4) interpersonal relationships.3 
All of these contributing factors should address 
equally in each patients.
Given the various assessment strategies and 
potential interventions available, the challenge 
for the treatment team is to select the techniques 
that provide the best fit for their treatment 
setting, resources, and patient population. The 
complexity of this topic and the importance of 
adherence encourage clinicians to continue to 
seek novel, patient-centered ways to prevent non-
adherence and to tailor adherence interventions. 
Early detection of non-adherence and prompt 
intervention can greatly reduce the development 
of viral resistance and the likelihood of virologic 
failure.4 On this edition, Surilena et al.5 have 
shown the influence of emotive behavior therapy 
to HAART adherence particularly in female 
patient.
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